Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy

NCT01652560 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Bevacizumab
Neoadjuvant Chemotherapy
Molecular Targeted Therapy

Interventions

DRUG: bevacizumab

Sponsor

LiNanlin,Ph.D, Chief Physician,Clinical Professor

Collaborators

[object Object]